Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vito Michele Fazio

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Biotechnology Letters|April 18, 2008
Mouse monoclonal antibodies in biological research: strategies for high-throughput productionPieranna Chiarella, Vito Michele Fazio
Cancers|February 12, 2021
EphA2 and EGFR: Friends in Life, Partners in Crime. Can EphA2 Be a Predictive Biomarker of Response to Anti-EGFR Agents?Mario Cioce, Vito Michele Fazio
Journal of Thoracic Disease|February 3, 2017
Keap1/Nrf2 impairing revised: are we missing the single nucleotide polymorphisms?Lucia Anna Muscarella, Vito Michele Fazio
Current Drug Metabolism|November 3, 2012
Electroporation in DNA vaccination protocols against cancerPieranna Chiarella, Vito Michele Fazio, Emanuela Signori
Cancers|June 28, 2023
Mapping Non-Coding RNAs in Space and Time: Another Weapon to Dissect Intra-Tumor Heterogeneity in Cancer ProgressionMario Cioce, Andrea Marra, Daniela Rutigliano, et al.
Cancer Drug Resistance (Alhambra, Calif.)|September 30, 2022
Butein-instigated miR-186-5p-dependent modulation of TWIST1 affects resistance to cisplatin and bioenergetics of Malignant Pleural Mesothelioma cellsMario Cioce, Daniela Rutigliano, Annamaria Puglielli, et al.
Biotechnology Advances|July 13, 2011
Epitope-driven DNA vaccine design employing immunoinformatics against B-cell lymphoma: a biotech's challengeSandra Iurescia, Daniela Fioretti, Vito Michele Fazio, et al.
Journal of Biomedicine & Biotechnology|April 7, 2010
DNA vaccines: developing new strategies against cancerDaniela Fioretti, Sandra Iurescia, Vito Michele Fazio, et al.
Current Gene Therapy|June 30, 2011
Design and pre-clinical development of epitope-based DNA vaccines against B-cell lymphomaSandra Iurescia, Daniela Fioretti, Vito Michele Fazio, et al.
Current Drug Metabolism|November 3, 2012
In vivo DNA electrotransfer for immunotherapy of cancer and neurodegenerative diseasesDaniela Fioretti, Sandra Iurescia, Vito Michele Fazio, et al.
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Biotechnology Letters|April 18, 2008
Mouse monoclonal antibodies in biological research: strategies for high-throughput productionPieranna Chiarella, Vito Michele Fazio
Cancers|February 12, 2021
EphA2 and EGFR: Friends in Life, Partners in Crime. Can EphA2 Be a Predictive Biomarker of Response to Anti-EGFR Agents?Mario Cioce, Vito Michele Fazio
Journal of Thoracic Disease|February 3, 2017
Keap1/Nrf2 impairing revised: are we missing the single nucleotide polymorphisms?Lucia Anna Muscarella, Vito Michele Fazio
Current Drug Metabolism|November 3, 2012
Electroporation in DNA vaccination protocols against cancerPieranna Chiarella, Vito Michele Fazio, Emanuela Signori
Cancers|June 28, 2023
Mapping Non-Coding RNAs in Space and Time: Another Weapon to Dissect Intra-Tumor Heterogeneity in Cancer ProgressionMario Cioce, Andrea Marra, Daniela Rutigliano, et al.
Cancer Drug Resistance (Alhambra, Calif.)|September 30, 2022
Butein-instigated miR-186-5p-dependent modulation of TWIST1 affects resistance to cisplatin and bioenergetics of Malignant Pleural Mesothelioma cellsMario Cioce, Daniela Rutigliano, Annamaria Puglielli, et al.
Biotechnology Advances|July 13, 2011
Epitope-driven DNA vaccine design employing immunoinformatics against B-cell lymphoma: a biotech's challengeSandra Iurescia, Daniela Fioretti, Vito Michele Fazio, et al.
Journal of Biomedicine & Biotechnology|April 7, 2010
DNA vaccines: developing new strategies against cancerDaniela Fioretti, Sandra Iurescia, Vito Michele Fazio, et al.
Current Gene Therapy|June 30, 2011
Design and pre-clinical development of epitope-based DNA vaccines against B-cell lymphomaSandra Iurescia, Daniela Fioretti, Vito Michele Fazio, et al.
Current Drug Metabolism|November 3, 2012
In vivo DNA electrotransfer for immunotherapy of cancer and neurodegenerative diseasesDaniela Fioretti, Sandra Iurescia, Vito Michele Fazio, et al.
Pageof 9